InterCure Statistics
Total Valuation
InterCure has a market cap or net worth of $78.89 million. The enterprise value is $116.12 million.
Important Dates
The next estimated earnings date is Tuesday, March 4, 2025, before market open.
| Earnings Date | Mar 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
InterCure has 45.77 million shares outstanding. The number of shares has increased by 0.82% in one year.
| Current Share Class | 45.77M |
| Shares Outstanding | 45.77M |
| Shares Change (YoY) | +0.82% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 25.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.09 |
| Forward PS | 0.22 |
| PB Ratio | 0.64 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.60 |
| EV / EBITDA | 148.11 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.78 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 19.01 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -13.61% and return on invested capital (ROIC) is -0.28%.
| Return on Equity (ROE) | -13.61% |
| Return on Assets (ROA) | -0.23% |
| Return on Invested Capital (ROIC) | -0.28% |
| Return on Capital Employed (ROCE) | -0.56% |
| Revenue Per Employee | $268,226 |
| Profits Per Employee | -$64,553 |
| Employee Count | 270 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 1.48 |
Taxes
In the past 12 months, InterCure has paid $1.43 million in taxes.
| Income Tax | 1.43M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.21% in the last 52 weeks. The beta is 0.15, so InterCure's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -19.21% |
| 50-Day Moving Average | 1.61 |
| 200-Day Moving Average | 1.99 |
| Relative Strength Index (RSI) | 48.89 |
| Average Volume (20 Days) | 29,660 |
Short Selling Information
The latest short interest is 41,085, so 0.09% of the outstanding shares have been sold short.
| Short Interest | 41,085 |
| Short Previous Month | 43,103 |
| Short % of Shares Out | 0.09% |
| Short % of Float | 0.16% |
| Short Ratio (days to cover) | 3.18 |
Income Statement
In the last 12 months, InterCure had revenue of $72.42 million and -$17.43 million in losses. Loss per share was -$0.38.
| Revenue | 72.42M |
| Gross Profit | 20.71M |
| Operating Income | -788,824 |
| Pretax Income | -15.91M |
| Net Income | -17.43M |
| EBITDA | 784,043 |
| EBIT | -788,824 |
| Loss Per Share | -$0.38 |
Full Income StatementBalance Sheet
The company has $5.39 million in cash and $40.06 million in debt, giving a net cash position of -$34.66 million or -$0.76 per share.
| Cash & Cash Equivalents | 5.39M |
| Total Debt | 40.06M |
| Net Cash | -34.66M |
| Net Cash Per Share | -$0.76 |
| Equity (Book Value) | 122.74M |
| Book Value Per Share | 2.56 |
| Working Capital | 43.01M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 28.60%, with operating and profit margins of -1.09% and -24.07%.
| Gross Margin | 28.60% |
| Operating Margin | -1.09% |
| Pretax Margin | -22.73% |
| Profit Margin | -24.07% |
| EBITDA Margin | 1.08% |
| EBIT Margin | -1.09% |
| FCF Margin | n/a |